ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Singapore investors plow into health care startups

Patented innovations plus government support make sector highly attractive

Kuldeep Singh Rajput is founder and CEO of Biofourmis, a startup that has developed an AI platform that can analyze data quickly to identify symptoms of heart attacks and other ailments.

SINGAPORE -- Singaporean investors are plowing into startups in the health care sector, drawn by the industry's innovations and strong government support.

Biofourmis, a startup originally from Singapore which recently shifted its headquarters to Boston, is one such example. The company plans to raise $100 million to $200 million in 2021, after bagging $35 million from U.S. investment fund Sequoia India, Openspace Ventures of Singapore and the Singapore government's venture capital arm EDBI.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more